Harbour Capital Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Harbour Capital Advisors's BIIB Position: Q1 2024 in Review
Harbour Capital Advisors sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,025 shares — an estimated $270K sold.
Harbour Capital Advisors first reported a position in BIIB in Q4 2014 and held it in 20 quarters. The position peaked at $1.22M in Q3 2018. 954 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.
- Harbour Capital Advisors reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
- Harbour Capital Advisors sold 1,025 Biogen shares in Q1 2024, an estimated $270K.
- Harbour Capital Advisors first reported a position in Biogen in Q4 2014 and held it in 20 quarters.
- Harbour Capital Advisors's Biogen position peaked at $1.22M in Q3 2018.
- 954 funds tracked by Wall St. Rank held Biogen as of Q1 2024.
Based on Harbour Capital Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.